| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8526368 | Biomedicine & Pharmacotherapy | 2018 | 7 Pages |
Abstract
This study provides new insight into the mechanism responsible for the development of human ESCC. Therefore, miR-30c could be a promising biomarker and a therapeutic target for ESCC in the future.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Teng Ma, Ye Zhao, Qitong Lu, Yun Lu, Zhiyong Liu, Tao Xue, Yongfeng Shao,